Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Surgeons not good at predicting benefit from knee operations

Surgeons are no better at determining which patients might benefit from operations to treat torn knee cartilage than if they just flipped a coin, a new study suggests.

Read More »

Liver disease related to obesity and diabetes rising in U.S.

The only liver disease becoming more widespread in the U.S. is one driven by obesity and diabetes – NAFLD – even as other liver disorder types linked to drinking or hepatitis become less common.

Read More »

Rutgers’ Nanotechnology Research Might Help with Alzheimer’s, Parkinson’s and Other Diseases

Researchers at Rutgers University-New Brunswick recently published research about a nanotechnology platform that helps identify what happens to specific stem cells.

Read More »

Regeneron’s Evinacumab Effective in Treating Rare, Inherited High-Cholesterol Disease

Regeneron Pharmaceuticals announced positive results from the company’s pivotal Phase III clinical trial of evinacumab in homozygous familial hypercholesterolemia (HoFH).

Read More »

Lilly’s Taltz Shows Superiority Over J&J’s Tremfya In Psoriasis Study

Eli Lilly announced that the company’s psoriasis drug Taltz overcame Johnson & Johnson’s Tremfya in a head-to-head study.

Read More »

MS Drug May Be Effective in Treating Brain Cancer

Published research shows promise in using Sanofi’s multiple sclerosis drug Aubagio in addition to targeted cancer therapy to treat the aggressive brain cancer glioblastoma.

Read More »

Regeneron’s Ebola drug outperforms rival in study

Regeneron Pharmaceuticals Inc. said the company’s experimental treatment for Ebola proved superior to a rival therapy from Mapp Biopharmaceutical at preventing death.

Read More »

AstraZeneca’s Tagrisso helps lung cancer patients live longer: study

AstraZeneca Plc said a late-stage study showed the company’s top-selling drug Tagrisso had significantly helped patients with a type of lung cancer live longer without the disease worsening.

Read More »

Study shows Apple devices in combo with apps could identify dementia

Drugmaker Eli Lilly and Company said early results from a study suggest that Apple Inc. devices, including the iPhone, in combination with digital apps could differentiate people with mild Alzheimer’s disease dementia and those without symptoms.

Read More »

Foamix Submits New Drug Application to U.S. FDA for FMX103

Foamix Pharmaceuticals Ltd. announced that the company submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for FMX103 for the treatment of moderate-to-severe papulopustular rosacea in patients 18 years of age and older.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom